Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer
- 30 June 2009
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 91 (3) , 353-359
- https://doi.org/10.1016/j.radonc.2008.10.006
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non–small-cell lung cancer: Long-term results of a radiation dose escalation studyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I TrialJournal of Clinical Oncology, 2004
- Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapyRadiotherapy and Oncology, 2004
- Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancerLung Cancer, 2004
- High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trialInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I TrialJournal of Clinical Oncology, 2001
- Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung CancerChest, 2000
- Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999